1-tert-butylazetidine;2-(1-tert-butylazetidin-3-yl)-3-fluoropyridine;2-(1-tert-butylazetidin-3-yl)pyrimidine;1-tert-butyl-3,3-difluoroazetidine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3,3-difluoropyrrolidine;1-tert-butyl-4-fluoropiperidine;(3R)-1-tert-butyl-3-methoxypyrrolidine;2-tert-butyl-6-methylpyridine;4-tert-butylmorpholine;4-tert-butylmorpholin-3-one;4-tert-butyloxane;2-tert-butyl-1,3-oxazole;1-tert-butyl-4-propan-2-ylpiperazine;4-tert-butyl-1-propan-2-ylpiperidine;2-tert-butylpyridine;1-tert-butylpyrrolidin-2-one;4-tert-butyl-1,4-thiazinane 1,1-dioxide;4-tert-butyl-1-(2,2,2-trifluoroethyl)piperidine
C173H321F11N22O9S — CID 160594999
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-tert-butylazetidine;2-(1-tert-butylazetidin-3-yl)-3-fluoropyridine;2-(1-tert-butylazetidin-3-yl)pyrimidine;1-tert-butyl-3,3-difluoroazetidine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3,3-difluoropyrrolidine;1-tert-butyl-4-fluoropiperidine;(3R)-1-tert-butyl-3-methoxypyrrolidine;2-tert-butyl-6-methylpyridine;4-tert-butylmorpholine;4-tert-butylmorpholin-3-one;4-tert-butyloxane;2-tert-butyl-1,3-oxazole;1-tert-butyl-4-propan-2-ylpiperazine;4-tert-butyl-1-propan-2-ylpiperidine;2-tert-butylpyridine;1-tert-butylpyrrolidin-2-one;4-tert-butyl-1,4-thiazinane 1,1-dioxide;4-tert-butyl-1-(2,2,2-trifluoroethyl)piperidine
1-tert-butylazetidine;2-(1-tert-butylazetidin-3-yl)-3-fluoropyridine;2-(1-tert-butylazetidin-3-yl)pyrimidine;1-tert-butyl-3,3-difluoroazetidine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3,3-difluoropyrrolidine;1-tert-butyl-4-fluoropiperidine;(3R)-1-tert-butyl-3-methoxypyrrolidine;2-tert-butyl-6-methylpyridine;4-tert-butylmorpholine;4-tert-butylmorpholin-3-one;4-tert-butyloxane;2-tert-butyl-1,3-oxazole;1-tert-butyl-4-propan-2-ylpiperazine;4-tert-butyl-1-propan-2-ylpiperidine;2-tert-butylpyridine;1-tert-butylpyrrolidin-2-one;4-tert-butyl-1,4-thiazinane 1,1-dioxide;4-tert-butyl-1-(2,2,2-trifluoroethyl)piperidine (PubChem CID 160594999) has the molecular formula C173H321F11N22O9S and a molecular weight of 3094.66 g/mol. Its IUPAC name is 1-tert-butylazetidine;2-(1-tert-butylazetidin-3-yl)-3-fluoropyridine;2-(1-tert-butylazetidin-3-yl)pyrimidine;1-tert-butyl-3,3-difluoroazetidine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3,3-difluoropyrrolidine;1-tert-butyl-4-fluoropiperidine;(3R)-1-tert-butyl-3-methoxypyrrolidine;2-tert-butyl-6-methylpyridine;4-tert-butylmorpholine;4-tert-butylmorpholin-3-one;4-tert-butyloxane;2-tert-butyl-1,3-oxazole;1-tert-butyl-4-propan-2-ylpiperazine;4-tert-butyl-1-propan-2-ylpiperidine;2-tert-butylpyridine;1-tert-butylpyrrolidin-2-one;4-tert-butyl-1,4-thiazinane 1,1-dioxide;4-tert-butyl-1-(2,2,2-trifluoroethyl)piperidine.
Molecular Properties
| Compound Name | 1-tert-butylazetidine;2-(1-tert-butylazetidin-3-yl)-3-fluoropyridine;2-(1-tert-butylazetidin-3-yl)pyrimidine;1-tert-butyl-3,3-difluoroazetidine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3,3-difluoropyrrolidine;1-tert-butyl-4-fluoropiperidine;(3R)-1-tert-butyl-3-methoxypyrrolidine;2-tert-butyl-6-methylpyridine;4-tert-butylmorpholine;4-tert-butylmorpholin-3-one;4-tert-butyloxane;2-tert-butyl-1,3-oxazole;1-tert-butyl-4-propan-2-ylpiperazine;4-tert-butyl-1-propan-2-ylpiperidine;2-tert-butylpyridine;1-tert-butylpyrrolidin-2-one;4-tert-butyl-1,4-thiazinane 1,1-dioxide;4-tert-butyl-1-(2,2,2-trifluoroethyl)piperidine |
|---|---|
| PubChem CID | 160594999 |
| Molecular Formula | C173H321F11N22O9S |
| Molecular Weight | 3094.66 g/mol |
| Exact Mass | 3092.49 |
| IUPAC Name | 1-tert-butylazetidine;2-(1-tert-butylazetidin-3-yl)-3-fluoropyridine;2-(1-tert-butylazetidin-3-yl)pyrimidine;1-tert-butyl-3,3-difluoroazetidine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3,3-difluoropyrrolidine;1-tert-butyl-4-fluoropiperidine;(3R)-1-tert-butyl-3-methoxypyrrolidine;2-tert-butyl-6-methylpyridine;4-tert-butylmorpholine;4-tert-butylmorpholin-3-one;4-tert-butyloxane;2-tert-butyl-1,3-oxazole;1-tert-butyl-4-propan-2-ylpiperazine;4-tert-butyl-1-propan-2-ylpiperidine;2-tert-butylpyridine;1-tert-butylpyrrolidin-2-one;4-tert-butyl-1,4-thiazinane 1,1-dioxide;4-tert-butyl-1-(2,2,2-trifluoroethyl)piperidine |
| SMILES | CC(C)(C)C1CCN(CC(F)(F)F)CC1.CC(C)(C)C1CCOCC1.CC(C)(C)N1CC(F)(F)C1.CC(C)(C)N1CC(c2ncccc2F)C1.CC(C)(C)N1CC(c2ncccn2)C1.CC(C)(C)N1CCC(F)(F)C1.CC(C)(C)N1CCC(F)(F)CC1.CC(C)(C)N1CCC(F)CC1.CC(C)(C)N1CCC1.CC(C)(C)N1CCCC1=O.CC(C)(C)N1CCOCC1.CC(C)(C)N1CCOCC1=O.CC(C)(C)N1CCS(=O)(=O)CC1.CC(C)(C)c1ccccn1.CC(C)(C)c1ncco1.CC(C)N1CCC(C(C)(C)C)CC1.CC(C)N1CCN(C(C)(C)C)CC1.CO[C@@H]1CCN(C(C)(C)C)C1.Cc1cccc(C(C)(C)C)n1 |
| InChI | InChI=1S/C12H17FN2.C12H25N.C11H20F3N.C11H17N3.C11H24N2.C10H15N.C9H17F2N.C9H18FN.C9H19NO.C9H13N.C9H18O.C8H15F2N.C8H17NO2S.C8H15NO2.C8H17NO.C8H15NO.C7H13F2N.C7H11NO.C7H15N/c1-12(2,3)15-7-9(8-15)11-10(13)5-4-6-14-11;1-10(2)13-8-6-11(7-9-13)12(3,4)5;1-10(2,3)9-4-6-15(7-5-9)8-11(12,13)14;1-11(2,3)14-7-9(8-14)10-12-5-4-6-13-10;1-10(2)12-6-8-13(9-7-12)11(3,4)5;1-8-6-5-7-9(11-8)10(2,3)4;1-8(2,3)12-6-4-9(10,11)5-7-12;1-9(2,3)11-6-4-8(10)5-7-11;1-9(2,3)10-6-5-8(7-10)11-4;1-9(2,3)8-6-4-5-7-10-8;1-9(2,3)8-4-6-10-7-5-8;1-7(2,3)11-5-4-8(9,10)6-11;1-8(2,3)9-4-6-12(10,11)7-5-9;1-8(2,3)9-4-5-11-6-7(9)10;1-8(2,3)9-4-6-10-7-5-9;1-8(2,3)9-6-4-5-7(9)10;1-6(2,3)10-4-7(8,9)5-10;1-7(2,3)6-8-4-5-9-6;1-7(2,3)8-5-4-6-8/h4-6,9H,7-8H2,1-3H3;10-11H,6-9H2,1-5H3;9H,4-8H2,1-3H3;4-6,9H,7-8H2,1-3H3;10H,6-9H2,1-5H3;5-7H,1-4H3;4-7H2,1-3H3;8H,4-7H2,1-3H3;8H,5-7H2,1-4H3;4-7H,1-3H3;8H,4-7H2,1-3H3;4-6H2,1-3H3;4-7H2,1-3H3;4-6H2,1-3H3;4-7H2,1-3H3;4-6H2,1-3H3;4-5H2,1-3H3;4-5H,1-3H3;4-6H2,1-3H3/t;;;;;;;;8-;;;;;;;;;;/m........1........../s1 |
| InChIKey | RDMYGMWJMUSPTC-QRVUJCRCSA-N |
| XLogP | 37.14 |
| TPSA | 247.52 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 29 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 216 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3094.66 |
| LogP ≤ 5 | 37.14 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 29 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160594999 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.